Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease

Clinical trial NCT03352557 · TERMINATED

Trial details

NCT number: NCT03352557
Sponsor: Biogen
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2018-05-03
Primary completion: 2021-08-30
Enrollment: 654

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.